Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents
- 1 April 2001
- Vol. 57 (4) , 132-136
- https://doi.org/10.1016/s0090-4295(00)00958-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, 1998
- Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2Biochemical and Biophysical Research Communications, 1997
- Characterization of the Precursor of Prostate-specific AntigenJournal of Biological Chemistry, 1997
- Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisUrology, 1997
- Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and ageUrology, 1996
- Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancerUrology, 1996
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new eraUrology, 1995
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987